Approaches to improve photodynamic therapy of cancer

Frontiers in Bioscience

Volumn 16, Issue 1, 2011, Pages 208-224

  Firczuk, Malgorzata ^a   Winiarska, Magdalena ^a   Szokalska, Angelika ^a   Jodlowska, Malgorzata ^a   Swiech, Marta ^a   Bojarczuk, Kami ^a   Salwa, Pawel ^a   Nowis, Dominika ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Cancer; Laser; Neoplasia; Photodynamic therapy; Photosensitiser; Review; Tumor

Indexed keywords

ANTINEOPLASTIC AGENT; PHOTOSENSITIZING AGENT; REACTIVE OXYGEN METABOLITE;

ADAPTIVE IMMUNITY; AMBULATORY CARE; ANIMAL; DRUG EFFECT; HUMAN; METABOLISM; METHODOLOGY; MULTIMODALITY CANCER THERAPY; NANOTECHNOLOGY; NEOPLASM; OXIDATIVE STRESS; PHOTOCHEMOTHERAPY; REVIEW; SKIN TUMOR;

ADAPTIVE IMMUNITY; AMBULATORY CARE; ANIMALS; ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; HUMANS; NANOTECHNOLOGY; NEOPLASMS; OXIDATIVE STRESS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; REACTIVE OXYGEN SPECIES; SKIN NEOPLASMS;

EID: 79955041217     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3684     Document Type: Article

References (163)

1. O. Raab: Uber die Wirkung fluorischeider Stoffe auf Infusora. Z Biol (39), 524-526 (1900)
2. H. von Tappeiner, Jesionek, A.: Therapeutische Versuche mit fluorescierenden Stoffen. Munch Med Wochenschr (47), 2042-2044 (1903)
3. R. Roelandts: The history of phototherapy: something new under the sun? J Am Acad Dermatol, 46(6), 926-30 (2002)
4. T. J. Dougherty, C. J. Gomer, B. W. Henderson, G. Jori, D. Kessel, M. Korbelik, J. Moan and Q. Peng: Photodynamic therapy. J Natl Cancer Inst, 90(12), 889-905 (1998) (Pubitemid 28304157)
5. A. P. Castano, P. Mroz and M. R. Hamblin: Photodynamic therapy and anti-tumour immunity. Nat Rev Cancer, 6(7), 535-45 (2006) (Pubitemid 43980542)
6. K. Plaetzer, B. Krammer, J. Berlanda, F. Berr and T. Kiesslich: Photophysics and photochemistry of photodynamic therapy: fundamental aspects. Lasers Med Sci., 24, 259-268 (2009)
7. A. O'Connor, W. Gallagher and A. Byrne: Porphyrin and nonporphyrin photosensitizers in oncology: preclinical and clinical advances in photodynamic therapy. Photochem Photobiol, 85, 1053-1074 (2009)
8. R. Allison, G. Downie, R. Cuenca, X. Hu, C. Childs and C. Sibata: Photosensitizers in clinical PDT. Photodiagnosis and Photodynamic Therapy, 1(1), 27-42 (2004) (Pubitemid 40311381)
9. A. Ronn, J. Batti, C. Lee, D. Yoo, M. Siegel, M. Nouri, L. Lofgren and B. Steinberg: Comparative biodistribution of meta-Tetra(Hydroxyphenyl) chlorin in multiple species: clinical implications for photodynamic therapy. Lasers Surg Med., 20, 437-442 (1997)
10. Q. Chen, Z. Huang, D. Luck, J. Beckers, P. Brun, B. Wilson, A. Scherz, Y. Salomon and F. Hetzel: Preclinical studies in normal canine prostate of a novel palladiumbacteriopheophorbide (WST09) photosensitizer for photodynamic therapy of prostate cancers. Photochem Photobiol., 76, 438-445 (2002)
11. S. Young, K. Woodburn, M. Wright, T. Mody, Q. Fan, J. Sessler, W. Dow and R. Miller: Lutetium texaphyrin (PCI-0123): a near-infrared, water-soluble photosensitizer. Photochem Photobiol., 63, 892-7 (1996) (Pubitemid 126467656)
12. Keiichi Sakamotoa, Eiko Ohno-Okumuraa, Taku Katoa, Masaki Watanabea and M. J. Cookc: Investigation of zinc bis(1,4-didecylbenzo)-bis(2,3-pyrido) porphyrazine as an efficient photosensitizer by cyclic voltammetry., 78, 213-218 (2008)
13. Fangdi Cong, Bo Ning, Yiping Ji, Xiuyan Wang, Fubo Ke, Yunyu Liu, Xiujun Cui and B. Chen: The facile synthesis and characterization of tetraimido-substituted zinc phthalocyanines. Dyes and Pigments, 77, 686-690 (2008) (Pubitemid 350148983)
14. Jiang XJ, Lo PC, Tsang YM, Yeung SL, Fong WP and K. P. N. D.: Phthalocyanine-Polyamine Conjugates as pHControlled Photosensitizers for Photodynamic Therapy. Chemistry (2010)
15. J. Rovers, A. Saarnak, M. de Jode, H. Sterenborg, O. Terpstra and M. Grahn: Biodistribution and bioactivity of tetrapegylated meta- tetra(hydroxyphenyl)chlorin compared to native meta-tetra(hydroxyphenyl)chlorin in a rat liver tumor model. Photochem Photobiol., 71, 211-217 (2000)
16. Silva J, Silva A, Tomé J, Ribeiro A, Domingues M, Cavaleiro J, M. Silva A, Neves G, Tomé A, Serra O, Bosca F, Filipe P, Santus R and M. P.: Photophysical properties of a photocytotoxic fluorinated chlorin conjugated to four betacyclodextrins. Photochem. Photobiol. Sci., 7, 834-843 (2008) (Pubitemid 351931551)
17. S. Ben Dror, I. Bronshtein, H. Weitman, P. Jacobi and B. Ehrenberg: Eur Biophys J.. The binding of analogs of porphyrins and chlorins with elongated side chains to albumin., 38, 847-855 (2009)
18. K. Stefflova, L. Hui, C. Juan and G. Zheng: Peptidebased pharmacomodulation of a cancer-targeted optical imaging and photodynamic therapy agent. Bioconjug Chem., 18, 379-388 (2007) (Pubitemid 46493508)
19. M. Hamblin and E. Newman: Photosensitizer targeting in photodynamic therapy. II. Conjugates of haematoporphyrin with serum lipoproteins. J Photochem Photobiol B., 26, 147-57. (1994) (Pubitemid 24345424)
20. R. Hudson, M. Carcenac, K. Smith, L. Madden, O. Clarke, A. Pèlegrin, J. Greenman and R. Boyle: The development and characterisation of porphyrin isothiocyanate-monoclonal antibody conjugates for photoimmunotherapy. Br J Cancer., 92, 1442-1449 ( 2005) (Pubitemid 40705011)
21. C. Staneloudi, K. Smith, R. Hudson, N. Malatesti, H. Savoie, R. Boyle and J. Greenman: Development and characterization of novel photosensitizer : scFv conjugates for use in photodynamic therapy of cancer. Immunology, 120, 512-517 (2007) (Pubitemid 46365009)
22. Y. Fang, Y. Huang, P. Wu and Y. Tsai: Topical delivery of 5-aminolevulinic acid-encapsulated ethosomes in a hyperproliferative skin animal model using the CLSM technique to evaluate the penetration behavior. Eur J Pharm Biopharm., 73, 391-398 (2009)
23. J. Schwiertz, A. Wiehe, S. Gräfe, B. Gitter and M. Epple: Calcium phosphate nanoparticles as efficient carriers for photodynamic therapy against cells and bacteria. Biomaterials., 30, 3324-31 (2009)
24. A. Molinari, C. Bombelli, S. Mannino, A. Stringaro, L. Toccacieli, A. Calcabrini, M. Colone, A. Mangiola, G. Maira, P. Luciani, G. Mancini and G. Arancia: m-THPCmediated photodynamic therapy of malignant gliomas: assessment of a new transfection strategy. Int J Cancer., 121, 1149-55. (2007) (Pubitemid 47101655)
25. A. Samia, X. Chen and C. Burda: Semiconductor Quantum Dots for Photodynamic Therapy J. Am. Chem. Soc., 125, 15736-15737 (2003) (Pubitemid 37553678)
26. J. Tsay, M. Trzoss, L. Shi, X. Kong, M. Selke, M. Jung and S. Weiss: Singlet oxygen production by Peptide-coated quantum dot-photosensitizer conjugates. J Am Chem Soc., 129, 6865-71 (2007) (Pubitemid 46847529)
27. P. Mroz, G. Tegos, H. Gali, T. Wharton, T. Sarna and M. Hamblin: Photodynamic therapy with fullerenes. Photochem Photobiol Sci., 6, 1139-49 (2007) (Pubitemid 350064036)
28. L. Brancaleon and H. Moseley: Laser and non-laser light sources for photodynamic therapy. Lasers Med Sci, 17(3), 173-86 (2002)
29. T. Theodossiou, J. S. Hothersall, E. A. Woods, K. Okkenhaug, J. Jacobson and A. J. MacRobert: Firefly luciferin-activated rose bengal: in vitro photodynamic therapy by intracellular chemiluminescence in transgenic NIH 3T3 cells. Cancer Res, 63(8), 1818-21 (2003) (Pubitemid 36460843)
30. Y. Koide, Y. Urano, A. Yatsushige, K. Hanaoka, T. Terai and T. Nagano: Design and development of enzymatically activatable photosensitizer based on unique characteristics of thiazole orange. J Am Chem Soc, 131(17), 6058-9 (2009)
31. L. M. Wood, D. A. Bellnier, A. R. Oseroff and W. R. Potter: A beam-splitting device for use with fiber-coupled laser light sources for photodynamic therapy. Photochem Photobiol, 76(6), 683-5 (2002)
32. N. Davies, Wilson, B.C.: Tetherless fiber-coupled optical source for extended metronomic photodynamic therapy. Photodiagnosis Photodyn Ther. (4), 184-189 (2007) (Pubitemid 47239503)
33. H. Moseley, J. W. Allen, S. Ibbotson, A. Lesar, A. McNeill, M. A. Camacho-Lopez, I. D. Samuel, W. Sibbett and J. Ferguson: Ambulatory photodynamic therapy: a new concept in delivering photodynamic therapy. Br J Dermatol, 154(4), 747-50 (2006) (Pubitemid 43374104)
34. S. K. Attili, A. Lesar, A. McNeill, M. Camacho-Lopez, H. Moseley, S. Ibbotson, I. D. Samuel and J. Ferguson: An open pilot study of ambulatory photodynamic therapy using a wearable low-irradiance organic light-emitting diode light source in the treatment of nonmelanoma skin cancer. Br J Dermatol, 161(1), 170-3 (2009)
35. M. Atif, Dyer, P.E., Paget, T.A., Snelling, H.V., Stringer, M.R.: Two-photon excitation studies of mTHPC photosensitizer and photodynamic activity in an epithelial cell line. Photodiagnosis Photodyn Ther, 4(2), 196-111 (2007)
36. J. Weng and J. Ren: Luminescent quantum dots: a very attractive and promising tool in biomedicine. Curr Med Chem, 13(8), 897-909 (2006)
37. V. Biju, S. Mundayoor, R. V. Omkumar, A. Anas and M. Ishikawa: Bioconjugated quantum dots for cancer research: present status, prospects and remaining issues. Biotechnol Adv, 28(2), 199-213 (2010)
38. W. Chen and J. Zhang: Using nanoparticles to enable simultaneous radiation and photodynamic therapies for cancer treatment. J Nanosci Nanotechnol, 6(4), 1159-66 (2006) (Pubitemid 44578047)
39. D. K. Chatterjee, L. S. Fong and Y. Zhang: Nanoparticles in photodynamic therapy: an emerging paradigm. Adv Drug Deliv Rev, 60(15), 1627-37 (2008)
40. D. Nowis, Golab, J.: Photodynamic therapy and oxidative stress. In: Advances in photodynamic therapy: basic, translational, and clinical. Ed M. Hamblin, Mroz, P. Artech House, Boston, London (2008)
41. V. Dolgachev, L. W. Oberley, T. T. Huang, J. M. Kraniak, M. A. Tainsky, K. Hanada and D. Separovic: A role for manganese superoxide dismutase in apoptosis after photosensitization. Biochem Biophys Res Commun, 332(2), 411-7 (2005)] (Pubitemid 40724994)
42. J. Golab, D. Nowis, M. Skrzycki, H. Czeczot, A. Baranczyk-Kuzma, G. M. Wilczynski, M. Makowski, P. Mroz, K. Kozar, R. Kaminski, A. Jalili, M. Kopec, T. Grzela and M. Jakobisiak: Antitumor effects of photodynamic therapy are potentiated by 2- methoxyestradiol. A superoxide dismutase inhibitor. J Biol Chem, 278(1), 407-14 (2003) (Pubitemid 36043590)
43. M. Athar, H. Mukhtar, C. A. Elmets, M. T. Zaim, J. R. Lloyd and D. R. Bickers: In situ evidence for the involvement of superoxide anions in cutaneous porphyrin photosensitization. Biochem Biophys Res Commun, 151(3), 1054-9 (1988) (Pubitemid 18095227)
44. M. Makowski, Nowis, D., Golab, J.: Cytoprotective mechanisms in photodynamic therapy. In: Photodynamic therapy at the cellular level. Ed A. Uzdensky. Research Signpost, Kerala (2007)
45. A. C. Miller and B. W. Henderson: The influence of cellular glutathione content on cell survival following photodynamic treatment in vitro. Radiat Res, 107(1), 83-94 (1986) (Pubitemid 16077459)
46. H. P. Wang, S. Y. Qian, F. Q. Schafer, F. E. Domann, L. W. Oberley and G. R. Buettner: Phospholipid hydroperoxide glutathione peroxidase protects against singlet oxygen-induced cell damage of photodynamic therapy. Free Radic Biol Med, 30(8), 825-35 (2001) (Pubitemid 32289260)
47. T. Kuhara, D. Watanabe, Y. Akita, T. Takeo, N. Ishida, A. Nakano, N. Yamashita, Y. Ohshima, M. Kawada, T. Yanagishita, Y. Tamada and Y. Matsumoto: Thioredoxin upregulation by 5-aminolaevulinic acidbased photodynamic therapy in human skin squamous cell carcinoma cell line. Photodermatol Photoimmunol Photomed, 24(3), 142-6 (2008) (Pubitemid 351682229)
48. Y. Lu, R. Jiao, X. Chen, J. Zhong, J. Ji and P. Shen: Methylene blue-mediated photodynamic therapy induces mitochondria-dependent apoptosis in HeLa cell. J Cell Biochem, 105(6), 1451-60 (2008)
49. H. P. Wang, J. G. Hanlon, A. J. Rainbow, M. Espiritu and G. Singh: Up-regulation of Hsp27 plays a role in the resistance of human colon carcinoma HT29 cells to photooxidative stress. Photochem Photobiol, 76 (1), 98-104 (2002)
50. A. Jalili, M. Makowski, T. Switaj, D. Nowis, G. M. Wilczynski, E. Wilczek, M. Chorazy-Massalska, A. Radzikowska, W. Maslinski, L. Bialy, J. Sienko, A. Sieron, M. Adamek, G. Basak, P. Mroz, I. W. Krasnodebski, M. Jakobisiak and J. Golab: Effective photoimmunotherapy of murine colon carcinoma induced by the combination of photodynamic therapy and dendritic cells. Clin Cancer Res, 10(13), 4498-508 (2004) (Pubitemid 38878894)
51. M. Korbelik, J. Sun and I. Cecic: Photodynamic therapy-induced cell surface expression and release of heat shock proteins: relevance for tumor response. Cancer Res, 65(3), 1018-26 (2005) (Pubitemid 40216464)
52. A. Ferrario, N. Rucker, S. Wong, M. Luna and C. J. Gomer: Survivin, a member of the inhibitor of apoptosis family, is induced by photodynamic therapy and is a target for improving treatment response. Cancer Res, 67(10), 4989-95 (2007) (Pubitemid 46910208)
53. A. Szokalska, M. Makowski, D. Nowis, G. M. Wilczynski, M. Kujawa, C. Wojcik, I. Mlynarczuk-Bialy, P. Salwa, J. Bil, S. Janowska, P. Agostinis, T. Verfaillie, M. Bugajski, J. Gietka, T. Issat, E. Glodkowska, P. Mrowka, T. Stoklosa, M. R. Hamblin, P. Mroz, M. Jakobisiak and J. Golab: Proteasome inhibition potentiates antitumor effects of photodynamic therapy in mice through induction of endoplasmic reticulum stress and unfolded protein response. Cancer Res, 69(10), 4235-43 (2009)
54. E. L. Eskelinen: Doctor Jekyll and Mister Hyde: autophagy can promote both cell survival and cell death. Cell Death Differ, 12 Suppl 2, 1468-72 (2005)
55. L. M. Davids, B. Kleemann, S. Cooper and S. H. Kidson: Melanomas display increased cytoprotection to hypericin-mediated cytotoxicity through the induction of autophagy. Cell Biol Int, 33(10), 1065-72 (2009)
56. D. Kessel, M. G. Vicente and J. J. Reiners, Jr.: Initiation of apoptosis and autophagy by photodynamic therapy. Autophagy, 2(4), 289-90 (2006) (Pubitemid 44342371)
57. D. Kessel and A. S. Arroyo: Apoptotic and autophagic responses to Bcl-2 inhibition and photodamage. Photochem Photobiol Sci, 6(12), 1290-5 (2007) (Pubitemid 350191106)
58. D. Nowis, M. Legat, T. Grzela, J. Niderla, E. Wilczek, G. M. Wilczynski, E. Glodkowska, P. Mrowka, T. Issat, J. Dulak, A. Jozkowicz, H. Was, M. Adamek, A. Wrzosek, S. Nazarewski, M. Makowski, T. Stoklosa, M. Jakobisiak and J. Golab: Heme oxygenase- 1 protects tumor cells against photodynamic therapymediated cytotoxicity. Oncogene, 25(24), 3365-74 (2006) (Pubitemid 43880305)
59. C. J. Gomer, M. Luna, A. Ferrario and N. Rucker: Increased transcription and translation of heme oxygenase in Chinese hamster fibroblasts following photodynamic stress or Photofrin II incubation. Photochem Photobiol, 53(2), 275-9 (1991)
60. M. C. Luna, A. Ferrario, N. Rucker and C. J. Gomer: Decreased expression and function of alpha-2 macroglobulin receptor/low density lipoprotein receptor-related protein in photodynamic therapy-resistant mouse tumor cells. Cancer Res, 55(9), 1820-3 (1995)
61. G. Singh, B. C. Wilson, S. M. Sharkey, G. P. Browman and P. Deschamps: Resistance to photodynamic therapy in radiation induced fibrosarcoma-1 and Chinese hamster ovary-multi-drug resistant. Cells in vitro. Photochem Photobiol, 54(2), 307-12 (1991)
62. Y. Ohgari, Y. Nakayasu, S. Kitajima, M. Sawamoto, H. Mori, O. Shimokawa, H. Matsui and S. Taketani: Mechanisms involved in delta-aminolevulinic acid (ALA)- induced photosensitivity of tumor cells: relation of ferrochelatase and uptake of ALA to the accumulation of protoporphyrin. Biochem Pharmacol, 71(1-2), 42-9 (2005) (Pubitemid 41713525)
63. K. Inoue, T. Karashima, M. Kamada, T. Shuin, A. Kurabayashi, M. Furihata, H. Fujita, K. Utsumi and J. Sasaki: Regulation of 5-aminolevulinic acid-mediated protoporphyrin IX accumulation in human urothelial carcinomas. Pathobiology, 76(6), 303-14 (2009)
64. W. Zhong, J. P. Celli, I. Rizvi, Z. Mai, B. Q. Spring, S. H. Yun and T. Hasan: In vivo high-resolution fluorescence microendoscopy for ovarian cancer detection and treatment monitoring. Br J Cancer, 101(12), 2015-22 (2009)
65. F. Aziz, S. Telara, H. Moseley, C. Goodman, P. Manthri and M. S. Eljamel: Photodynamic therapy adjuvant to surgery in metastatic carcinoma in brain. Photodiagnosis Photodyn Ther, 6(3-4), 227-30 (2009)
66. J. Usuda, S. Ichinose, T. Ishizumi, H. Hayashi, K. Ohtani, S. Maehara, S. Ono, N. Kajiwara, O. Uchida, H. Tsutsui, T. Ohira, H. Kato and N. Ikeda: Management of multiple primary lung cancer in patients with centrally located early cancer lesions. J Thorac Oncol, 5(1), 62-8 (2010)
67. T. Momma, M. R. Hamblin, H. C. Wu and T. Hasan: Photodynamic therapy of orthotopic prostate cancer with benzoporphyrin derivative: local control and distant metastasis. Cancer Res, 58(23), 5425-31 (1998) (Pubitemid 28551126)
68. Z. Luksiene, P. Juzenas and J. Moan: Radiosensitization of tumours by porphyrins. Cancer Lett, 235(1), 40-7 (2006)
69. B. W. Pogue, J. A. O'Hara, E. Demidenko, C. M. Wilmot, I. A. Goodwin, B. Chen, H. M. Swartz and T. Hasan: Photodynamic therapy with verteporfin in the radiationinduced fibrosarcoma-1 tumor causes enhanced radiation sensitivity. Cancer Res, 63(5), 1025-33 (2003) (Pubitemid 36278434)
70. R. Allman, P. Cowburn and M. Mason: Effect of photodynamic therapy in combination with ionizing radiation on human squamous cell carcinoma cell lines of the head and neck. Br J Cancer, 83(5), 655-61 (2000) (Pubitemid 30636309)
71. P. Sharma, T. Farrell, M. S. Patterson, G. Singh, J. R. Wright, R. Sur and A. J. Rainbow: In vitro survival of nonsmall cell lung cancer cells following combined treatment with ionizing radiation and photofrin-mediated photodynamic therapy. Photochem Photobiol, 85(1), 99-106 (2009)
72. S. P. Creekmore and D. S. Zaharko: Modification of chemotherapeutic effects on L1210 cells using hematoporphyrin and light. Cancer Res, 43(11), 5252-7 (1983) (Pubitemid 14230135)
73. M. F. Zuluaga and N. Lange: Combination of photodynamic therapy with anti-cancer agents. Curr Med Chem, 15(17), 1655-73 (2008)
74. A. J. French, S. N. Datta, R. Allman and P. N. Matthews: Investigation of sequential mitomycin C and photodynamic therapy in a mitomycin-resistant bladder cancer cell-line model. BJU Int, 93(1), 156-61 (2004) (Pubitemid 38120234)
75. J. C. Bremner, J. K. Bradley, G. E. Adams, M. A. Naylor, J. M. Sansom and I. J. Stratford: Comparing the anti-tumor effect of several bioreductive drugs when used in combination with photodynamic therapy (PDT). Int J Radiat Oncol Biol Phys, 29(2), 329-32 (1994) (Pubitemid 24166541)
76. R. J. Skyrme, A. J. French, S. N. Datta, R. Allman, M. D. Mason and P. N. Matthews: A phase-1 study of sequential mitomycin C and 5-aminolaevulinic acidmediated photodynamic therapy in recurrent superficial bladder carcinoma. BJU Int, 95(9), 1206-10 (2005) (Pubitemid 40799431)
77. A. Ferrario, K. Von Tiehl, S. Wong, M. Luna and C. J. Gomer: Cyclooxygenase-2 inhibitor treatment enhances photodynamic therapy-mediated tumor response. Cancer Res, 62(14), 3956-61 (2002) (Pubitemid 34791059)
78. M. Makowski, T. Grzela, J. Niderla, L. A. M, P. Mroz, M. Kopee, M. Legat, K. Strusinska, K. Koziak, D. Nowis, P. Mrowka, M. Wasik, M. Jakobisiak and J. Golab: Inhibition of cyclooxygenase-2 indirectly potentiates antitumor effects of photodynamic therapy in mice. Clin Cancer Res, 9(14), 5417-22 (2003) (Pubitemid 37413598)
79. K. K. Yee, K. C. Soo and M. Olivo: Anti-angiogenic effects of Hypericin-photodynamic therapy in combination with Celebrex in the treatment of human nasopharyngeal carcinoma. Int J Mol Med, 16(6), 993-1002 (2005)
80. F. Jiang, X. Zhang, S. N. Kalkanis, Z. Zhang, H. Yang, M. Katakowski, X. Hong, X. Zheng, Z. Zhu and M. Chopp: Combination therapy with antiangiogenic treatment and photodynamic therapy for the nude mouse bearing U87 glioblastoma. Photochem Photobiol, 84(1), 128-37 (2008) (Pubitemid 350265084)
81. J. H. Woodhams, A. J. Macrobert and S. G. Bown: The role of oxygen monitoring during photodynamic therapy and its potential for treatment dosimetry. Photochem Photobiol Sci, 6(12), 1246-56 (2007) (Pubitemid 350191109)
82. B. W. Henderson, S. O. Gollnick, J. W. Snyder, T. M. Busch, P. C. Kousis, R. T. Cheney and J. Morgan: Choice of oxygen-conserving treatment regimen determines the inflammatory response and outcome of photodynamic therapy of tumors. Cancer Res, 64(6), 2120-6 (2004) (Pubitemid 38339462)
83. T. M. Sitnik, J. A. Hampton and B. W. Henderson: Reduction of tumour oxygenation during and after photodynamic therapy in vivo: effects of fluence rate. Br J Cancer, 77(9), 1386-94 (1998) (Pubitemid 28190737)
84. D. B. Cairnduff F, Vernon D, Brown SB: The effect of hyperbaric oxygen on the photodynamic response of a rodent fibrosarcoma. In: Photodynamic Therapy and Biomedical Lasers. Ed D. F. M. Spinelli P, Marchesini R. (1992)
85. Q. Chen, Z. Huang, H. Chen, H. Shapiro, J. Beckers and F. W. Hetzel: Improvement of tumor response by manipulation of tumor oxygenation during photodynamic therapy. Photochem Photobiol, 76(2), 197-203 (2002)
86. M. A. Matzi V, Sankin O, Lindenmann J, Woltsche M, Smolle J, Smolle-Juttner FM: Photodynamic therapy enhanced by hyperbaric oxygenation in palliation of malignant pleural mesothelioma: clinical experience. Photodiagnosis and Photodynamic Therapy(1), 57-64 (2004)
87. V. H. Fingar, T. S. Mang and B. W. Henderson: Modification of photodynamic therapy-induced hypoxia by fluosol-DA (20%) and carbogen breathing in mice. Cancer Res, 48(12), 3350-4 (1988)
88. J. Golab, D. Olszewska, P. Mroz, K. Kozar, R. Kaminski, A. Jalili and M. Jakobisiak: Erythropoietin restores the antitumor effectiveness of photodynamic therapy in mice with chemotherapy-induced anemia. Clin Cancer Res, 8(5), 1265-70 (2002) (Pubitemid 34517667)
89. M. Korbelik, G. Krosl, J. Krosl and G. Dougherty: The role of host lymphoid populations in the response of mouse EMT6 tumor to photodynamic therapy. Cancer Res, 56, 5647-5652 (1996) (Pubitemid 26422167)
90. S. Gollnick, B. Owczarczak and P. Maier: Photodynamic therapy and anti-tumor immunity. Lasers Surg Med, 38, 509-515 (2006)
91. M. Korbelik and G. Dougherty: Photodynamic therapymediated immune response against subcutaneous mouse tumors. Cancer Res, 59, 1941-1946 (1999) (Pubitemid 29186169)
92. E. Kabingu, A. Oseroff, G. Wilding and S. O. Gollnick: Enhanced systemic immune reactivity to a Basal cell carcinoma associated antigen following photodynamic therapy. Clin Cancer Res, 15, 4460-4466 (2009)
93. D. Preise, R. Oren, I. Glinert, V. Kalchenko, S. Jung, A. Scherz and Y. Salomon: Systemic antitumor protection by vascular-targeted photodynamic therapy involves cellular and humoral immunity. Cancer Immunol Immunother, 58, 71-84 (2009)
94. D. King, H. Jiang, G. Simkin, M. Obochi, J. Levy and D. Hunt: Photodynamic alteration of the surface receptor expression pattern of murine splenic dendritic cells. Scand J Immunol, 49, 184-192 (1999) (Pubitemid 29096315)
95. A. Garg, D. Nowis, J. Golab, P. Vandenabeele, D. Krysko and P. Agostinis: Immunogenic cell death, DAMPs and anticancer therapeutics: An emerging amalgamation. Biochim Biophys Acta, 1805, 53-71 (2010)
96. M. Korbelik: PDT-associated host response and its role in the therapy outcome. Lasers Surg Med, 38, 500-508 (2006)
97. M. Korbelik and I. Cecic: Enhancement of tumour response to photodynamic therapy by adjuvant mycobacterium cell-wall treatment J Photochem Photobiol, 44, 151-158 (1998) (Pubitemid 28505179)
98. R. Myers, B. Lau, D. Kunihira, R. Torrey, J. Woolley and J. Tosk: Modulation of hematoporphyrin derivativesensitized phototherapy with corynebacterium parvum in murine transitional cell carcinoma. Urology, 33, 230-235 (1989) (Pubitemid 19089651)
99. G. Krosl and M. Korbelik: Potentiation of photodynamic therapy by immunotherapy: the effect of schizophyllan (SPG).. Cancer Lett, 29, 43-49 (1994) (Pubitemid 24260281)
100. W. Chen, M. Korbelik, K. Bartels, H. Liu, J. Sun and R. Nordquist: Enhancement of laser cancer treatment by a chitosan-derived immunoadjuvant. Photochem Photobiol, 81, 190-195 (2005) (Pubitemid 40327579)
101. M. Korbelik and P. Cooper: Potentiation of photodynamic therapy of cancer by complement: the effect of gamma-inulin. Br J Cancer, 96, 67-72 (2007) (Pubitemid 46094641)
102. M. Korbelik, J. Sun, I. Cecic and K. Serrano: Adjuvant treatment for complement activation increases the effectiveness of photodynamic therapy of solid tumors. Photochem Photobiol Sci, 3, 812-816 (2004) (Pubitemid 39302983)
103. S. Gollnick, S. Evans, H. Baumann, B. Owczarczak, P. Maier, L. Vaughan, W. Wang, E. Unger and B. Henderson: Role of cytokines in photodynamic therapyinduced local and systemic inflammation. Br J Cancer, 88, 1772-1779 (2003) (Pubitemid 36760423)
104. S. Gollnick, X. Liu, B. Owczarczak, D. Musser and B. Henderson: Altered expression of interleukin 6 and interleukin 10 as a result of photodynamic therapy in vivo. Cancer Res, 57, 3904-3909 (1997) (Pubitemid 27427673)
105. S. Herman, Y. Kalechman, U. Gafter, B. Sredni and Z. Malik: Photofrin II induces cytokine secretion by mouse spleen cells and human peripheral mononuclear cells. Immunopharmacology(31), 195-204 (1996) (Pubitemid 26122647)
106. J. Golab, G. Wilczynski, R. Zagozdzon, T. Stoklosa, A. Dabrowska, J. Rybczynska, M. Wasik, E. Machaj, T. Olda, K. Kozar, R. Kaminski, A. Giermasz, A. Czajka, W. Lasek, W. Feleszko and M. Jakóbisiak: Potentiation of the anti-tumour effects of Photofrin-based photodynamic therapy by localized treatment with G-CSF. Br J Cancer, 82, 1485-1491 (2000) (Pubitemid 30175918)
107. G. Krosl, M. Korbelik, J. Krosl and G. Dougherty: Potentiation of photodynamic therapy-elicited antitumor response by localized treatment with granulocytemacrophage colony-stimulating factor. Cancer Res, 56, 3281-3286 (1996) (Pubitemid 26242977)
108. E. Park, Bae, SM, Kwak, SY, Lee, SJ, Kim, YW, Han, CH, Cho, HJ, Kim, KT, Kim, YJ, Kim, HJ, Ahn, WS.: Photodynamic therapy with recombinant adenovirus AdmIL-12 enhances anti-tumour therapy efficacy in human papillomavirus 16 (E6/E7) infected tumour model. Immunology, 124, 461-468 (2008) (Pubitemid 351962542)
109. D. Granville, H. Jiang, B. McManus and D. Hunt: Fas ligand and TRAIL augment the effect of photodynamic therapy on the induction of apoptosis in JURKAT cells. Int Immunopharmacol, 1, 1831-1840 (2001) (Pubitemid 32772653)
110. W. Chen, A. Singhal, H. Liu and R. Nordquist: Antitumor immunity induced by laser immunotherapy and its adoptive transfer. Cancer Res, 61, 459-461 (2001) (Pubitemid 32128597)
111. A. Jalili, M. Makowski, T. Switaj, D. Nowis, G. Wilczynski, E. Wilczek, M. Chorazy-Massalska, A. Radzikowska, W. Maslinski, L. Bialy, J. Sienko, A. Sieron, M. Adamek, G. Basak, P. Mróz, I. Krasnodebski, M. Jakóbisiak and J. Golab: Effective hotoimmunotherapy of murine colon carcinoma induced by the combination of photodynamic therapy and dendritic cells. Clin Cancer Res, 10, 4498-4508 (2004) (Pubitemid 38878894)
112. H. Saji, W. Song, K. Furumoto, H. Kato and E. Engleman: Systemic antitumor effect of intratumoral injection of dendritic cells in combination with local photodynamic therapy. Clin Cancer Res, 12, 2568-2574 (2006)
113. M. Korbelik and J. Sun: Cancer treatment by photodynamic therapy combined with adoptive immunotherapy using genetically altered natural killer cell line. Int J Cancer, 93, 269-274 (2001) (Pubitemid 32574284)
114. V. Dima, M. Ionescu, C. Balotescu, S. Dima, V. Vasiliu and D. Lacky: New approach to the adoptive immunotherapy of Walker-256 carcinosarcoma with activated macrophages combined with photodynamic therapy. Roum Arch Microbiol Immunol, 60, 237-256 (2001)
115. A. Castano, Q. Liu and M. Hamblin: A green fluorescent protein-expressing murine tumour but not its wild-type counterpart is cured by photodynamic therapy. Br J Cancer, 94, 391-397 (2006) (Pubitemid 43237563)
116. U. Winters, S. Daayana, J. Lear, A. Tomlinson, E. Elkord, P. Stern and H. Kitchener: Clinical and immunologic results of a phase II trial of sequential imiquimod and photodynamic therapy for vulval intraepithelial neoplasia. Clin Cancer Res, 14, 5292-5299 (2008)
117. D. Bellnier, S. Gollnick, S. Camacho, W. Greco and R. Cheney: Treatment with the tumor necrosis factor-alphainducing drug 5,6-dimethylxanthenone-4- acetic acid enhances the antitumor activity of the photodynamic therapy of RIF-1 mouse tumors. Cancer Res, 63, 7584-7590 (2003) (Pubitemid 37466677)
118. A. Castano, P. Mroz, M. Wu and M. Hamblin: Photodynamic therapy plus low-dose cyclophosphamide generates antitumor immunity in a mouse model. Proc Natl Acad Sci USA, 105, 5495-5500 (2008) (Pubitemid 351753891)
119. B. Henderson, S. Gollnick, J. Snyder, T. Busch, P. Kousis, R. Cheney and J. Morgan: Choice of oxygenconserving treatment regimen determines the inflammatory response and outcome of photodynamic therapy of tumors. Cancer Res, 64, 2120-2126 (2004) (Pubitemid 38339462)
120. S. Gollnick, L. Vaughan and B. Henderson: Generation of effective antitumor vaccines using photodynamic therapy. Cancer Res, 62, 1604-1608 (2002) (Pubitemid 34408477)
121. M. Korbelik and J. Sun: Photodynamic therapygenerated vaccine for cancer therapy. Cancer Immunol Immunother, 55, 900-909 (2006) (Pubitemid 43673579)
122. K. Berg, P. K. Selbo, L. Prasmickaite, T. E. Tjelle, K. Sandvig, J. Moan, G. Gaudernack, O. Fodstad, S. Kjolsrud, H. Anholt, G. H. Rodal, S. K. Rodal and A. Hogset: Photochemical internalization: a novel technology for delivery of macromolecules into cytosol. Cancer Res, 59(6), 1180-3 (1999) (Pubitemid 29136242)
123. A. Baker and J. R. Kanofsky: Quenching of singlet oxygen by biomolecules from L1210 leukemia cells. Photochem Photobiol, 55(4), 523-8 (1992)
124. A. Hogset, L. Prasmickaite, T. E. Tjelle and K. Berg: Photochemical transfection: a new technology for lightinduced, site-directed gene delivery. Hum Gene Ther, 11(6), 869-80 (2000) (Pubitemid 30202478)
125. A. Hogset, B. O. Engesaeter, L. Prasmickaite, K. Berg, O. Fodstad and G. M. Maelandsmo: Light-induced adenovirus gene transfer, an efficient and specific gene delivery technology for cancer gene therapy. Cancer Gene Ther, 9(4), 365-71 (2002) (Pubitemid 34289455)
126. O. J. Norum, P. K. Selbo, A. Weyergang, K. E. Giercksky and K. Berg: Photochemical internalization (PCI) in cancer therapy: from bench towards bedside medicine. J Photochem Photobiol B, 96(2), 83-92 (2009)
127. P. K. Selbo, G. Sivam, O. Fodstad, K. Sandvig and K. Berg: Photochemical internalisation increases the cytotoxic effect of the immunotoxin MOC31-gelonin. Int J Cancer, 87(6), 853-9 (2000) (Pubitemid 30660566)
128. A. Weyergang, P. K. Selbo and K. Berg: Photochemically stimulated drug delivery increases the cytotoxicity and specificity of EGF-saporin. J Control Release, 111(1-2), 165-73 (2006) (Pubitemid 43290005)
129. W. L. Yip, A. Weyergang, K. Berg, H. H. Tonnesen and P. K. Selbo: Targeted delivery and enhanced cytotoxicity of cetuximab-saporin by photochemical internalization in EGFR-positive cancer cells. Mol Pharm, 4(2), 241-51 (2007) (Pubitemid 46640600)
130. J. Woodhams, P. J. Lou, P. K. Selbo, A. Mosse, D. Oukrif, A. MacRobert, M. Novelli, Q. Peng, K. Berg and S. G. Bown: Intracellular re-localisation by photochemical internalisation enhances the cytotoxic effect of gelonin- quantitative studies in normal rat liver. J Control Release, 142(3), 347-53 (2010)
131. S. K. Bisland, L. Lilge, A. Lin, R. Rusnov and B. C. Wilson: Metronomic photodynamic therapy as a new paradigm for photodynamic therapy: rationale and preclinical evaluation of technical feasibility for treating malignant brain tumors. Photochem Photobiol, 80, 22-30 (2004)
132. L. Lilge, M. Portnoy and B. C. Wilson: Apoptosis induced in vivo by photodynamic therapy in normal brain and intracranial tumour tissue. Br J Cancer, 83(8), 1110-7 (2000)
133. N. Davies and B. C. Wilson: Interstitial in vivo ALAPpIX mediated metronomic photodynamic therapy (mPDT) using the CNS-1 astrocytoma with bioluminescence monitoring. Photodiag Photodyn Ther, 4, 202-212 (2007) (Pubitemid 47239507)
134. S. Verma, G. M. Watt, Z. Mai and T. Hasan: Strategies for enhanced photodynamic therapy effects. Photochem Photobiol, 83(5), 996-1005 (2007) (Pubitemid 47438530)
135. S. Wang, Gao, R., Zhou, F., Selke, M.: Nanomaterials and singlet oxygen photosensitizers: potential applications in photodynamic therapy. J. Mater. Chem.(14), 487-493 (2004)
136. W. Tang, H. Xu, R. Kopelman and M. A. Philbert: Photodynamic characterization and in vitro application of methylene blue-containing nanoparticle platforms. Photochem Photobiol, 81(2), 242-9 (2005) (Pubitemid 40551499)
137. I. Roy, T. Y. Ohulchanskyy, H. E. Pudavar, E. J. Bergey, A. R. Oseroff, J. Morgan, T. J. Dougherty and P. N. Prasad: Ceramic-based nanoparticles entrapping waterinsoluble photosensitizing anticancer drugs: a novel drugcarrier system for photodynamic therapy. J Am Chem Soc, 125(26), 7860-5 (2003) (Pubitemid 36782161)
138. J. R. Starkey, A. K. Rebane, M. A. Drobizhev, F. Meng, A. Gong, A. Elliott, K. McInnerney and C. W. Spangler: New two-photon activated photodynamic therapy sensitizers induce xenograft tumor regressions after near-IR laser treatment through the body of the host mouse. Clin Cancer Res, 14(20), 6564-73 (2008)
139. J. D. Bhawalkar, N. D. Kumar, C. F. Zhao and P. N. Prasad: Two-photon photodynamic therapy. J Clin Laser Med Surg, 15(5), 201-4 (1997) (Pubitemid 27518371)
140. M. Panjehpour and B. Overholt: Porfimer sodium photodynamic therapy for management of Barrett's esophagus with high-grade dysplasia. Lasers Surg Med, 38, 390-395 (2006)
141. E. de Haas, B. Kruijt, H. Sterenborg, H. Martino Neumann and D. Robinson: Fractionated illumination significantly improves the response of superficial basal cell carcinoma to aminolevulinic acid photodynamic therapy. J Invest Dermatol., 126, 2679-2686 (2006) (Pubitemid 44764052)
142. F. Raspagliesi, R. Fontanelli, G. Rossi, A. Ditto, E. Solima, F. Hanozet and S. Kusamura: Photodynamic therapy using a methyl ester of 5-aminolevulinic acid in recurrent Paget's disease of the vulva: a pilot study. Gynecol Oncol., 103, 581-586 (2006) (Pubitemid 44602172)
143. C. Betz, W. Rauschning, E. Stranadko, M. Riabov, V. Albrecht, N. Nifantiev and C. Hopper: Optimization of treatment parameters for Foscan-PDT of basal cell carcinomas. Lasers Surg Med, 40, 300-311 (2008) (Pubitemid 351920379)
144. T. Sato, S. Kishi, H. Matsumoto and R. Mukai: Combined Photodynamic Therapy with Verteporfin and Intravitreal Bevacizumab for Polypoidal Choroidal Vasculopathy. Am J Ophthalmol (2010)
145. G. M. Loewen, R. Pandey, D. Bellnier, B. Henderson and T. Dougherty: Endobronchial photodynamic therapy for lung cancer. Lasers Surg Med, 38(5), 364-70 (2006)
146. T. S. Mang, R. Allison, G. Hewson, W. Snider and R. Moskowitz: A phase II/III clinical study of tin ethyl etiopurpurin (Purlytin)-induced photodynamic therapy for the treatment of recurrent cutaneous metastatic breast cancer. Cancer J Sci Am, 4(6), 378-84 (1998)
147. M. Kujundzic, T. J. Vogl, D. Stimac, N. Rustemovic, R. A. Hsi, M. Roh, M. Katicic, R. Cuenca, R. A. Lustig and S. Wang: A Phase II safety and effect on time to tumor progression study of intratumoral light infusion technology using talaporfin sodium in patients with metastatic colorectal cancer. J Surg Oncol, 96(6), 518-24 (2007) (Pubitemid 350044397)
148. P. S. Thong, M. Olivo, K. W. Kho, R. Bhuvaneswari, W. W. Chin, K. W. Ong and K. C. Soo: Immune response against angiosarcoma following lower fluence rate clinical photodynamic therapy. J Environ Pathol Toxicol Oncol, 27(1), 35-42 (2008) (Pubitemid 351507421)
149. T. K. Lee, E. D. Baron and T. H. Foster: Monitoring Pc 4 photodynamic therapy in clinical trials of cutaneous Tcell lymphoma using noninvasive spectroscopy. J Biomed Opt, 13(3), 030507 (2008)
150. J. Woodhams, A. MacRobert, M. Novelli and S. Bown: Photodynamic therapy with WST09 (Tookad): quantitative studies in normal colon and transplanted tumours. Int J Cancer, 118, 477-482 (2006) (Pubitemid 41779090)
151. H. Patel, R. Mick, J. Finlay, T. C. Zhu, E. Rickter, K. A. Cengel, S. B. Malkowicz, S. M. Hahn and T. M. Busch: Motexafin lutetium-photodynamic therapy of prostate cancer: short- and long-term effects on prostate-specific antigen. Clin Cancer Res, 14(15), 4869-76 (2008)
152. M. Uehara, K. Sano, Z. Wang, J. Sekine, H. Ikeda and T. Inokuchi: Enhancement of the photodynamic antitumor effect by streptococcal preparation OK-432 in the mouse carcinoma. Cancer Immunol Immunother, 49, 401-409 (2000)
153. M. Korbelik, J. Sun and J. Posakony: Interaction between photodynamic therapy and BCG immunotherapy responsible for the reduced recurrence of treated mouse tumors. Photochem Photobiol, 73, 403-409 (2001)
154. S. Bae, Y. Kim, S. Kwak, Y. Kim, D. Ro, J. Shin, C. Park, S. Han, C. Oh, C. Kim and W. Ahn: Photodynamic therapy-generated tumor cell lysates with CpGoligodeoxynucleotide enhance immunotherapy efficacy in human papillomavirus 16 (E6/E7) immortalized tumor cells. Cancer Scie, 98, 747-752 (2007) (Pubitemid 46563453)
155. D. Bellnier: Potentiation of photodynamic therapy in mice with recombinant human tumor necrosis factor-alpha. J Photochem Photobiol B, 8, 203-210 (1991)
156. P. Mroz, A. Castano, M. Wu, A. Kung and M. Hamblin: Anti-tumor immune response after photodynamic therapy. Proc. SPIE, 7380 (2009)
157. E. R. Junior, Marchetti, J.M.: Zinc(II) phthalocyanine loaded PLGA nanoparticles for photodynamic therapy use. International Journal of Pharmaceutics (310), 187-195 (2006) (Pubitemid 43287983)
158. M. E. Wieder, D. C. Hone, M. J. Cook, M. M. Handsley, J. Gavrilovic and D. A. Russell: Intracellular photodynamic therapy with photosensitizer- nanoparticle conjugates: cancer therapy using a 'Trojan horse'. Photochem Photobiol Sci, 5(8), 727-34 (2006) (Pubitemid 44186866)
159. A. J. Gomes, C. N. Lunardi and A. C. Tedesco: Characterization of biodegradable poly(D,L-lactide-coglycolide) nanoparticles loaded with bacteriochlorophyll-a for photodynamic therapy. Photomed Laser Surg, 25(5), 428-35 (2007) (Pubitemid 350059049)
160. S. Kim, T. Y. Ohulchanskyy, H. E. Pudavar, R. K. Pandey and P. N. Prasad: Organically modified silica nanoparticles co-encapsulating photosensitizing drug and aggregation-enhanced two-photon absorbing fluorescent dye aggregates for two-photon photodynamic therapy. J Am Chem Soc, 129(9), 2669-75 (2007) (Pubitemid 46364075)
161. W. Tang, H. Xu, E. J. Park, M. A. Philbert and R. Kopelman: Encapsulation of methylene blue in polyacrylamide nanoparticle platforms protects its photodynamic effectiveness. Biochem Biophys Res Commun, 369(2), 579-83 (2008)
162. S. Chen ZL, Huang P, Yang XX, Zhou XP: Studies on Preparation of Photosensitizer Loaded Magnetic Silica Nanoparticles and Their Anti-Tumor Effects for Targeting Photodynamic Therapy. Nanoscale Res Lett (4), 400-408 (2009)
163. L. Zhou, J. H. Liu, J. Zhang, S. H. Wei, Y. Y. Feng, J. H. Zhou, B. Y. Yu and J. Shen: A new sol-gel silica nanovehicle preparation for photodynamic therapy in vitro. Int J Pharm, 386(1-2), 131-7 (2010)